CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
about
A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylationHuman T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.Function and histopathology of a cell adhesion molecule TSLC1 in cancer.The testicular germ cell tumour transcriptome.PDZ domains: the building blocks regulating tumorigenesis.Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia.LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1.Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer PatientsTumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway.Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer.CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.Identification of genes underlying the enhancement of immunity by a formula of lentinan, pachymaran and tremelia polysaccharides in immunosuppressive mice.
P2860
Q34113164-9C2A70E2-E2F3-47E9-BB2C-5E0386389C86Q35182251-DD8A6910-060C-473D-AEA6-B02DAF4BABECQ37844079-1495529B-8329-4B83-B930-696367A98FD4Q37886262-4E33F6B4-9F07-4718-BC91-1EA2D96BE557Q37939947-E6B5302D-3206-4010-BC0A-560A075741DFQ38930398-D73CCC8C-7DB2-4BA8-AA38-52175E318E0BQ38974695-5F8A86C2-19B9-4905-9E71-6A910799EAC4Q39132912-2D8FD054-1337-4782-B106-B49C875FAB6DQ39427615-795CB152-39C8-4E40-9D22-7FD44887AD11Q40316397-185967DB-B52A-410F-8FF3-8FEBBED70C25Q46208226-AA12941B-3C5B-4280-B563-06B9C35EDC2AQ51321204-FAD566C6-D3CC-4058-BE79-3967C42C592DQ52308826-D76F18C8-197A-4A96-AE43-AFDAC1E63938Q55662080-16F35059-1281-4518-965B-5004AA1BB4E2
P2860
CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CADM1/TSLC1 inactivation by pr ...... th late stages of the disease.
@en
CADM1/TSLC1 inactivation by pr ...... th late stages of the disease.
@nl
type
label
CADM1/TSLC1 inactivation by pr ...... th late stages of the disease.
@en
CADM1/TSLC1 inactivation by pr ...... th late stages of the disease.
@nl
prefLabel
CADM1/TSLC1 inactivation by pr ...... th late stages of the disease.
@en
CADM1/TSLC1 inactivation by pr ...... th late stages of the disease.
@nl
P2093
P2860
P356
P1476
CADM1/TSLC1 inactivation by pr ...... th late stages of the disease.
@en
P2093
Guanghai Wang
Haisheng Yu
Kequan Chen
Liang Peng
Shaoheng Zhang
Xiangsheng Fu
Yali Zhang
P2860
P304
P356
10.1002/IJC.25356
P577
2010-03-25T00:00:00Z